US pharmaceutical giant Merck to get new CEO

[NEW YORK] US pharmaceutical giant Merck said Thursday that chief executive Ken Frazier will retire on June 30.

Mr Frazier, one of few African Americans to run a major US company, will stay on the board as executive chairman during a transition period, a statement said.

Word of the change in leadership came as Merck reported profits of US$7.1 billion in 2020, a decline of 28 per cent from the previous year, on revenue of US$48 billion, which was up by 2.5 per cent.

AFP

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Sign UpVIEW ALL